Matthew R. Lammi

1.4k total citations
53 papers, 487 citations indexed

About

Matthew R. Lammi is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Matthew R. Lammi has authored 53 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Matthew R. Lammi's work include Pulmonary Hypertension Research and Treatments (26 papers), Systemic Sclerosis and Related Diseases (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). Matthew R. Lammi is often cited by papers focused on Pulmonary Hypertension Research and Treatments (26 papers), Systemic Sclerosis and Related Diseases (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). Matthew R. Lammi collaborates with scholars based in United States, Egypt and Switzerland. Matthew R. Lammi's co-authors include Lesley Ann Saketkoo, Gerard J. Criner, Nathaniel Marchetti, Mohamed A. Ghonim, David Ciccolella, A. Hamid Boulares, Bennett P. deBoisblanc, Amarjit S. Naura, Paulo C. Rodrı́guez and Moselhy S. Mansy and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Matthew R. Lammi

49 papers receiving 486 citations

Peers

Countries citing papers authored by Matthew R. Lammi

Since Specialization

Citations

This map shows the geographic impact of Matthew R. Lammi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Lammi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Lammi more than expected).

Fields of papers citing papers by Matthew R. Lammi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew R. Lammi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Lammi. The network helps show where Matthew R. Lammi may publish in the future.

Co-authorship network of co-authors of Matthew R. Lammi

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Lammi. A scholar is included among the top collaborators of Matthew R. Lammi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Lammi. Matthew R. Lammi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Innovating the Gold Standard: The Emerging Role of Echocardiographic Stress Testing in the Classification, Stratification, and Prognostication in Pulmonary Vascular Disease 2025 ·Current Cardiology Reports ·(unknown), (unknown), Valentina Mercurio, Steven Hsu, Matthew R. Lammi, Stephen C. Mathai, Luna Gargani, Monica Mukherjee	1
2	Medication Nonadherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR) 2025 ·Annals of the American Thoracic Society ·(unknown), (unknown), David B. Badesch, Charles D. Burger, (unknown), Teresa De Marco, Anna R. Hemnes, Matthew R. Lammi, Stephen C. Mathai, (unknown), Farhan Raza, Jeffrey S. Sager, Oksana A. Shlobin, Thenappan Thenappan, Roham T. Zamanian, James Runo, Grayson L. Baird, Corey E. Ventetuolo	1
3	Refining Risk Prediction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension 2025 ·Journal of the American Society of Echocardiography ·(unknown), Vivek Jani, (unknown), Abhishek Gami, (unknown), Steven Hsu, Laura K. Hummers, Fredrick M. Wigley, Matthew R. Lammi, Bharath Ambale‐Venkatesh, Paul M. Hassoun, Ami A. Shah, Stephen C. Mathai, Monica Mukherjee	0
4	Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset 2024 ·Cardiology and Therapy ·Richard N. Channick, Kelly Chin, Vallerie V. McLaughlin, Matthew R. Lammi, Roham T. Zamanian, (unknown), Rose Ong, Lada Mitchell, Nick H. Kim	2
5	ICU Management of the Patient With Fibrotic Interstitial Lung Disease 2023 ·(unknown), David R. Janz, Matthew R. Lammi	6
6	Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry 2023 ·Annals of the American Thoracic Society ·(unknown), Teresa De Marco, (unknown), Matthew R. Lammi, (unknown), John Ryan, Corey E. Ventetuolo, R. James White, Roham T. Zamanian, Peter J. Leary	7
7	STOP-Bang for OSA screening in patients with pulmonary hypertension 2023 ·Respiratory Medicine ·(unknown), (unknown), Lesley Ann Saketkoo, Shigeki Saito, Bennett P. deBoisblanc, Matthew R. Lammi	1
8	Medication Non-adherence and Health-related Outcomes in Patients With Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR) 2023 ·(unknown), (unknown), Grayson L. Baird, David B. Badesch, (unknown), (unknown), Teresa De Marco, (unknown), Matthew R. Lammi, (unknown), J.W. McConnell, (unknown), Farhan Raza, James Runo, (unknown), (unknown), Thenappan Thenappan, (unknown), Corey E. Ventetuolo	1
9	Pulmonary artery compliance in different forms of pulmonary hypertension 2023 ·Heart ·(unknown), (unknown), David B. Badesch, Raymond L. Benza, Todd Bull, Teresa De Marco, Jeremy Feldman, Anna R. Hemnes, Russel Hirsch, Evelyn M. Horn, (unknown), Stephen C. Mathai, (unknown), Steven C. Pugliese, Jeffrey S. Sager, Oksana A. Shlobin, Marc A. Simon, Matthew R. Lammi	8
10	Implementation of a Longitudinal Critical Care Fellowship Ultrasound Curriculum 2022 ·ATS Scholar ·(unknown), (unknown), Bennett P. deBoisblanc, (unknown), Stephen P. Kantrow, Matthew R. Lammi	3
11	Use of red cell distribution width in a population at high risk for pulmonary hypertension 2019 ·Respiratory Medicine ·(unknown), Lesley Ann Saketkoo, (unknown), Shigeki Saito, (unknown), Bennett P. deBoisblanc, Matthew R. Lammi	15
12	Clinical Differences in COPD Patients with Variable Patterns of Hypoxemia 2018 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·(unknown), Amanda L. Blackford, Matthew R. Lammi, Anne L. Fuhlbrigge, Xavier Soler, Richard Albert, Gerard J. Criner	3
13	PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4+ T cell function 2015 ·Journal of Translational Medicine ·Mohamed A. Ghonim, (unknown), Salomè V. Ibba, Amir A. Al-Khami, Jeffrey Wang, Paulo C. Rodrı́guez, (unknown), Ali H. El‐Bahrawy, Matthew R. Lammi, Moselhy S. Mansy, (unknown), Alistair J. Ramsay, Augusto C. Ochoa, Amarjit S. Naura, A. Hamid Boulares	43
14	Outcome Measures for Clinical Trials in Interstitial Lung Diseases 2015 ·Current Respiratory Medicine Reviews ·Matthew R. Lammi, Robert P. Baughman, Surinder S. Birring, Anne‐Marie Russell, Jay H. Ryu, Mary Beth Scholand, Oliver Distler, (unknown), Catherine Sarver, Κατερίνα Αντωνίου, Kristin B. Highland, Otylia Kowal‐Bielecka, Joseph A. Lasky, Athol U. Wells, Lesley Ann Saketkoo	32
15	Response to Fluid Boluses in the Fluid and Catheter Treatment Trial 2015 ·CHEST Journal ·Matthew R. Lammi, (unknown), (unknown), Tayyab Rehman, Ivor S. Douglas, Arthur P. Wheeler, Bennett P. deBoisblanc	31
16	Characteristics of Patients with Pulmonary Venoocclusive Disease Awaiting Transplantation 2014 ·Annals of the American Thoracic Society ·Keith Wille, Nirmal Sharma, Tejaswini Kulkarni, Matthew R. Lammi, Joseph B. Barney, (unknown), Ryan S. Cantor, David C. Naftel, Enrique Diaz‐Guzman, David C. McGiffin	22
17	DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4+ T-cell function without causing severe combined immunodeficiency 2014 ·Journal of Allergy and Clinical Immunology ·Mohamed A. Ghonim, (unknown), Jihang Ju, Paulo C. Rodrı́guez, Matthew R. Lammi, (unknown), (unknown), Moselhy S. Mansy, Amarjit S. Naura, A. Hamid Boulares	34
18	Heterogeneity of Lung Volume Reduction Surgery Outcomes in Patients Selected by Use of Evidence-Based Criteria 2013 ·The Annals of Thoracic Surgery ·Matthew R. Lammi, Nathaniel Marchetti, (unknown), Gerard J. Criner	6
19	Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation 2012 ·European Respiratory Journal ·Matthew R. Lammi, David Ciccolella, Nathaniel Marchetti, Malcolm Kohler, Gerard J. Criner	32
20	Pulmonary Tumor Embolism 2010 ·Lung ·Matthew R. Lammi, John Wurzel, Gerard J. Criner	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact